TABLE 1.
Oligonucleotides used in this study
Primer | Sequencea |
---|---|
CotE5′ | AGGAGGAGGCATATGTCTGAATACAGGGAAATTAT |
CotE3′ | TGGTGGTGGGAATTCTTATTCTTCAGGATCTCCC |
CotY5′ | AGGAGGAGGCATATGAGCTGCGGAAAAACCC |
CotY3′ | AGGAGGAGGGAATTCTTATCCATTGTGATGATGCTTTTTATC |
CotW5′ | AGGAGGAGGCATATGTCAGATAACGATAAATTCAAAG |
CotW3′ | GGAGGAGGAGAATTCCTAATTGTTATCGTTTTTCCGTC |
CotY5′Duet | TGGTGGTGGCATATGAGCTGCGGAAAAACCCATG |
CotY3′Duet | TGGTGGTGGCTCGAGTTATCCATTGTGATGATGCTTTTTATC |
CotZ5′Duet | TGGTGGTGGGAATTCAAGCCAGAAAACATCAAGCTG |
CotZ3′Duet | TGGTGGTGGGTCGACTTAATGATGATGTGTACGATTG |
CotV5′Duet | GATGATGATGGATCCTTCATTTGAAGAAAAAGTCGAATCC |
CotV3′Duet | ATGATGATGCTGCAGTTAAAGGACGTCAAGTTCACTAAG |
CotW3′Duet | GGAGGAGGACTCGAGCTAATTGTTATCGTTTTTCCGTC |
Y2HcotE5′ | GGGGACAAGTTTGTACAAAAAAGCAGGCTTCTCTGAATACAGGGAAATTATTACGAAGG |
Y2HcotE3b′ | GGGGACCACTTTGTACAAGAAAGCTGGGTCTCATTCTTCAGGATCTCCCACTAAAAAC |
Y2HcotX5′ | GGGGACAAGTTTGTACAAAAAAGCAGGCTTCGAAAGCAGACCATATTCTTGGG |
Y2HcotX3′ | GGGGACCACTTTGTACAAGAAAGCTGGGTCTCAGAGGACAAGAGTGATAACTAGG |
Y2HcotY5′ | GGGGACAAGTTTGTACAAAAAAGCAGGCTTCAGCTGCGGAAAAACCCATGG |
Y2HcotY3′ | GGGGACCACTTTGTACAAGAAAGCTGGGTCTCATCCATTGTGATGATGCTTTTTATCTTTG |
Y2HcotZ5′ | GGGGACAAGTTTGTACAAAAAAGCAGGCTTCAGCCAGAAAACATCAAGCTGCGTG |
Y2HcotZ3′ | GGGGACCACTTTGTACAAGAAAGCTGGGTCTTAATGATGATGTGTACGATTGATTAATCGAG |
Y2HcotV5′ | GGGGACAAGTTTGTACAAAAAAGCAGGCTTCTCATTTGAAGAAAAAGTCGAATCCCTG |
Y2HcotV3′ | GGGGACCACTTTGTACAAGAAAGCTGGGTCTTAAAGGACGTCAAGTTCACTAAGAATG |
Y2HcotW5′ | GGGGACAAGTTTGTACAAAAAAGCAGGCTTCTCAGATAACGATAAATTCAAAGAAGAGC |
Y2HcotW3′ | GGGGACCACTTTGTACAAGAAAGCTGGGTCTTAATTGTTATCGTTTTTCCGTCTTTGTC |
Restriction sites and attB1/attB2 sequences used for Gateway system cloning are underlined.